SCHEMBL5177995

SCHEMBL5177995

COC(C)(C)c1ccc(C=O)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.50
▸ TSHR P16473 1/20 0.42
▸ ALDH1A3 P47895 3/20 0.41
▸ ALDH3A1 P30838 2/20 0.41
▸ HPGD P15428 2/20 0.39
▸ AOX1 Q06278 1/20 0.39
▸ TRIM24 O15164 1/20 0.39
▸ ALDH5A1 P51649 1/20 0.39
▸ ABAT P80404 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ TRIM33 Q9UPN9 1/20 0.39
▸ NR3C1 P04150 1/20 0.38
▸ PGR P06401 1/20 0.38
▸ NR3C2 P08235 1/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ VCAM1 P19320 1/20 0.38
▸ CYP2A6 P11509 1/20 0.37
▸ FDPS P14324 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5188027 0.82 ALDH1A1 (0.57) ALDH1A1TSHRALDH1A3ALDH3A1HPGD
SCHEMBL472520 0.74 ALDH1A1 (0.57) ALDH1A1ALDH1A3ALDH3A1VCAM1HSD17B10
SCHEMBL29417704 0.74 ALDH1A1 (0.57) ALDH1A1ALDH1A3ALDH3A1VCAM1HSD17B10
SCHEMBL5177740 0.73 HPGD (0.36) ALDH1A1TSHRHPGDTDP1MAPT
SCHEMBL28229506 0.71 ALDH1A1 (0.53) ALDH1A1TSHRALDH1A3ALDH3A1TDP1
SCHEMBL9173511 0.71 ALDH1A1 (0.52) ALDH1A1TSHRALDH1A3ALDH3A1HPGD
SCHEMBL335717 0.71 ALDH1A1 (0.68) ALDH1A1TSHRALDH1A3HPGDAOX1
SCHEMBL29952908 0.71 ALDH1A1 (0.68) ALDH1A1TSHRALDH1A3HPGDAOX1
Ethane SCHEMBL2153516 0.69 ALDH1A1 (0.55) ALDH1A1TSHRALDH1A3ALDH3A1HPGD
SCHEMBL48577 0.68 ALDH1A1 (1.00) ALDH1A1TSHRALDH1A3ALDH3A1VCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7259183-B2 Indole, indazole and indoline derivatives as CETP inhibitors HOFFMANN-LA ROCHE INC. (US) 2007-08-21 — — US disclosed
EP-1776338-A1 INDOLE, INDAZOLE OR INDOLINE DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-04-25 — — EP disclosed
US-20060030613-A1 Indole, indazole and indoline derivatives as CETP inhibitors F. HOFFMANN-LA ROCHE AG (CH) 2006-02-09 — — US disclosed
WO-2006013048-A1 INDOLE, INDAZOLE OR INDOLINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-02-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030613-A1 Indole, indazole and indoline derivatives as CETP inhibitors CETP, NAT1, MTTP ALDH1A1 2428/4885TSHR 1890/4885ALDH1A3 3876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback